We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

12 hedge funds and large institutions have $615K invested in NeuroMetrix, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less capital invested

Capital invested by funds: $710K → $615K (-$95K)

20% less funds holding

Funds holding: 1512 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q3 2019 in Review

12 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2019, worth a combined $615K — down 13% from $710K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NURO and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 4 added.

The largest buyer was Sabby Management, adding an estimated $47K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $6K sold.

  • 12 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2019, down from 15 in Q2 2019.
  • Funds reported $615K of NeuroMetrix, Inc. Common Stock stock for Q3 2019, down 13% quarter-over-quarter.
  • 1 fund opened new NeuroMetrix, Inc. Common Stock positions in Q3 2019 and 4 closed out, a net change of -3 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2019 was Sabby Management, an estimated $47K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2019 was Two Sigma Securities, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2019.